SXTC Live signals | Maximize Profits with Getagraph.com

SELL 132756 min ago

@ $2.15

Issued: 14 Feb 2024 @ 13:52

Return: -49.77%

Previous signal: Feb 14 - 09:31

Previous signal: Buy

Return: 13.46 %

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 16:00):

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China...

Stats
Today's Volume	419 801
Average Volume	963 955
Market Cap	610 777
EPS	$0 ( 2023-10-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0400
ATR14	$0.00800 (0.75%)

Volume Correlation

Long: 0.11 (neutral)

Short: -0.32 (neutral)

Signal:(47.627) Neutral

China SXT Pharmaceuticals Correlation

10 Most Positive Correlations
HOFT	0.861
NDRA	0.861
APVO	0.858
LSXMA	0.856
ALLR	0.855
LSXMK	0.854
MRTN	0.849
SNFCA	0.849
WERN	0.847
CVBF	0.846

10 Most Negative Correlations
BLPH	-0.864
INTA	-0.861
MLTX	-0.846
FSLR	-0.838
MNDY	-0.838
LRMR	-0.83
RIVE	-0.828
DSEY	-0.828
DUOL	-0.828
GAIA	-0.824

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China SXT Pharmaceuticals Correlation - Currency/Commodity

0.25
( neutral )

-0.42
( neutral )

0.00
( neutral )

-0.43
( neutral )

0.00
( neutral )

-0.07
( neutral )

China SXT Pharmaceuticals Financials

Annual	2023
Revenue:	$1.97M
Gross Profit:	$426 271 (21.62 %)
EPS:	$-5.71

FY	2023
Revenue:	$1.97M
Gross Profit:	$426 271 (21.62 %)
EPS:	$-5.71

FY	2022
Revenue:	$2.60M
Gross Profit:	$1.25M (48.10 %)
EPS:	$-5.52

FY	2021
Revenue:	$4.78M
Gross Profit:	$2.84M (59.43 %)
EPS:	$-0.191

Financial Reports:

No articles found.

China SXT Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.